Product Code
|
Allele
|
Publication
|
|
TB-0008-1; TB-0008-2; TB-0008-4
|
HLA-A*02:01 HIV pol Tetramer-ILKEPVHGV
|
Shacklett BL, et al. J Virol 77: 5621-5631 (2003, BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
|
|
TB-0009-1
|
HLA-A*02:01 Mart-1 Tetramer-PE
|
Mantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI)
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Coughlin CM, et al. Blood 103: 2046-2054 (2004 BCI)
Tomiyama M, et al. Anticancer Res. 24: 3327-3334 (2004, MBL)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Casati C, et al. Cancer Res 66: 4450-4460 (2006 BCI)
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL)
Wong RM, et al. Int Immunol 19: 1223-1234 (2007 BCI)
Takahara M, et al. J. Leukoc. Biol. 83: 742-754 (2008)
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
Banchereau J, et al. PNAS 109: 18885-18890 (2012 BCI)
Bruns H, et al. Clin Cancer Res 21: 2075-2083 (2015, BCI)
McCracken MN, et al. J Clin Invest 125: 1815–1826 (2015, MBL)
|
TB-0010-1; TB-0010-2
|
HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV |
Shacklett BL, et al. J Virol 77: 5621-5631 (2003, BCI)
Aandahl EM, et al. J Immunol 170: 2349-2355 (2003 BCI)
Betts MR, et al. J Immunol 172: 6407-6417 (2004, BCI)
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Morita Y, et al. Bone Marrow Transplant 36: 803-811 (2005)
Komatsu H, et al. Immun Ageing 3: 11 (2006)
Comin-Anduix B, et al. Clin Cancer Res 12: 107-116 (2006, BCI)
Zhang H, et al. J Immunol 179: 4910-4918 (2007 BCI)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008)
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
Takamori A, et al. Retrovirology 8: 100 (2011)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Nakauchi Y, et al. Exp Hematol 43: 79–88 (2015, MBL)
|
TB-0011-1; TB-0011-2
|
HLA-A*02:01 EBV BMLF1 Tetramer-GLCTLVAML
|
Tomiyama M, et al. Anticancer Res. 24: 3327-3334 (2004)
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL)
Turtle CJ, et al. Immunity 31: 834-844 (2009 BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
Shultz LD, et al. PNAS 107: 13022-13027 (2010)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
Faustman DL, et al. PLoS One 7: e41756 (2012, BCI)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Sasawatari S, et al. Immunol Cell Biol 84: 512–521 (2006, MBL)
|
TB-0012-1; TB-0012-2; TB-0012-4
|
HLA-A*02:01 Influenza M1 Tetramer-GILGFVFTL |
Mantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI)
Aandahl EM. et al. J. Immunol. 170: 2349-2355 (2003 BCI)
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Coughlin CM, et al. Blood 103: 2046-2054 (2004 BCI)
Hess C, et al. Blood 104: 3463-3471 (2004 BCI)
Aandahl EM, et al. Blood 104: 3672-3678 (2004 BCI)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Moran TP, et al. J Immunol 175: 3431-3438 (2005 BCI)
Cooper LJN, et al. Blood 105: 1622-1631 (2005 BCI)
Yang S, et al. Clin Cancer Res 11: 5603-5615 (2005 BCI)
Naumov YN, et al. J Immunol 177: 2006-2014 (2006 BCI)
Casati C. et al. Cancer Res. 66: 4450-4460 (2006 BCI)
Zhang H, et al. J Immunol 179: 4910-4918 (2007 BCI)
Naumov YN, et al. J Immunol 181: 7407-7419 (2008)
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
He X-S, et al. J Infect Dis 197: 803-811 (2008 BCI)
Yu CI, et al. Blood 112: 3671-3678 (2008 BCI)
Turtle CJ, et al. Immunity 31: 834-844 (2009 BCI)
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
Harari A, et al. J Virol 83: 2862-2871 (2009 BCI)
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Tu W, et al. J Virol 84: 6527-6535 (2010 BCI)
Ndhlovu ZM, et al. PNAS 107: 3669-3674 (2010 BCI)
Alanio C, et al. Blood 115: 3718-3725 (2010 BCI)
Romano E, et al. Clin Cancer Res 17: 1984-1997 (2011 BCI)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
Flamar A-L, et al.J Immunol 189: 2645-2655 (2012 BCI)
Bruns H, et al. Clin Cancer Res 21: 2075-2083 (2015, BCI)
|
TB-0013-1; TB-0013-2
|
HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV |
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Wong RM, et al. Int Immunol 19: 1223-1234 (2007 BCI)
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
Frleta D, et al. J. Immunol 182: 2766-2776 (2009 BCI)
Romano E, et al. Clin. Cancer Res 17: 1984-1997 (2011 BCI)
|
| TB-0014-1; TB-0014-2 |
HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV |
Walker EB, et al. Clin. Cancer Res 14: 5270-5283 (2008 BCI)
Chung B, et al. Cell Reports 8: 871-882 (2014 MBLI)
|
TB-0015-1; TB-0015-2
|
HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL |
Faustman DL, et al. PLoS One 7: e41756 (2012, BCI) |
| TB-0019-4; TB-0019-1; TB-0019-2 |
HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV |
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
Akiyama Y, et al. J Transl Med 3: 4-13 (2005)
Romano E, et al. Clin Cancer Res 17: 1984-1997 (2011 BCI)
Mehrotra S, et al. J Immunol 189: 1627-1638 (2012 BCI)
|
| TB-0025-1; TB-0025-2 |
HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM |
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI)
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI)
|
| TB-0026-1; TB-0026-2 |
HLA-B*08:01 CMV IE1 Tetramer-ELRRKMMYM |
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI) |
| TB-0027-1; TB-0027-2 |
HLA-B*35:01 CMV pp65 Tetramer-IPSINVHHY |
Odumade OA, et al. J Exp Med 209: 471-478 (2012 BCI) |
| TS-M001-1 |
HLA-A*24:02 EBV LMP2 Tetramer-IYVLVMLVL-PE |
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
|
| TS-M002-1 |
HLA-A*24:02 EBV BRLF1 Tetramer-PE |
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
|
| TS-M003-1 |
HLA-A*24:02 EBV BMLF1Tetramer-PE |
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
|
| TS-M004-1 |
HLA-A*24:02 EBV EBNA3A Tetramer-PE |
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
|
| TS-M005-1 |
HLA-A*24:02 EBV EBNA3B Tetramer-PE |
Watanabe K, et al. Int J Hematol. 88: 311-320 (2008) BMLF1
Kozako T, et al. Leukemia 23: 375-382 (2009) , BRLF1
Sato K, et al. Blood 117: 5663-5673 (2011)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Ezinne CC, et al. PLoS One 9: e87631 (2014) , BRLF1
|
| TB-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-PE |
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Shultz LD, et al. PNAS 107: 13022-13027 (2010)
|
| TS-M007 |
HLA-A*24:02 Negative Tetramer-PE |
Akiyama Y, et al. J Transl Med 3: 4-13 (2005)
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J. Med Virol 79: 977-86 (2007)
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Tsukahara T, et al. Cancer Sci 99: 368-375 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Akiyama Y, et al. Anticancer Res 29: 647-655 (2009)
Kameshima H, et al. Cancer Sci 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci 104: 124-129 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Koido S, et al. Clin Cancer Res 20: 4228-4239 (2014, MBL)
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Najima Y, et al. Blood 127: 722-734 (2016, MBL)
Murata K et al. OncoImmunology DOI:10.1080/2162402X.2016.1165376
|
| TS-M008-1 |
H-2Kb Negative Tetramer-PE |
Asano J, et al. J Immunol 184: 736-745 (2010)
Wakita D, et al. Int Immunol 18: 425-434 (2006)
Chamoto K, et al. Cancer Res 66: 1809-1817 (2006)
Fujimura T, et al. Eur J Immunol 36: 3371-3380 (2006)
|
| TS-M009-1 |
HLA-A*24:02 EBV Mix Tetramer-PE |
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013) |
| TS-M010-1 |
HLA-A*24:02 hTERT Tetramer-PE |
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Mizukoshi E, et al. Hepatology 43: 1284-1294 (2006)
|
|
TB-M014-1
|
HLA-A*24:02 WT1 (modified) Tetramer-PE
HLA-A*24:02 WT1 (wild) Tetramer-PE
|
Tsuboi A, et al. Int J Hematol 86: 414-417 (2007)
Narita M, et al. Int J Med Sci 7: 72-81 (2010)
Chiba Y, et al. Jpn J Clin Oncol 40: 395-403 (2010)
Murao A, et al. Cancer Sci 101: 848-854 (2010, MBL)
Saitoh A, et al. Med Oncol 28: 219-230 (2011)
Tamanaka T, et al. Anticancer Res 32: 5201-5209 (2012)
Watanabe K, et al. Biomedical Res 34: 41-50 (2013)
Koido S, et al. Clin Cancer Res 20: 4228-4239 (2014)
Kobayashi M, et al. J Ovarian Res. 7:48 (2014)
Najima Y, et al. Blood 127: 722-734 (2016, MBL)
|
| TS-M140 |
HLA-A*02:01 WT1 Tetramer |
Kobayashi M, et al. J Ovarian Res. 7: 48 (2014)
Najima Y, et al. Blood 127: 722-734 (2016, MBL)
|
| TS-M018-1 |
HLA-A*24:02 HTLV-1 Tax301-309 Tetramer-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M019-1 |
HLA-A*02:01 HTLV-1 Tax178-186 Tetramer-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M020-1 |
HLA-A*24:02 HTLV-1 Tax12-20 Tetramer-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M021-1 |
HLA-A*24:02 HTLV-1 Tax187-195 Tetramer-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M022-1 |
HLA-A*24:02 HTLV-1 Env11-19 Tetramer-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M023-1 |
HLA-A*11:01 HTLV-1 Tax88-96 Tetramer-KVLTPPITH-PE |
Kozako T, et al. J Immunol 177: 5718-5726 (2006)
Akimoto M, et al. J Med Virol 79: 977-986 (2007)
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
Kozako T, et al. Leukemia 23: 375-382 (2009)
Tanaka Y, et al. Cancer Res 70: 6181-6192 (2010)
Takamori A, et al. Retrovirology 8: 100 (2011)
Kozako T, et al. Hum Immunol 72: 1001-1006 (2011)
Kozako T, et al. J Med Virol 83: 501-509 (2011)
Kozako T, et al. FEBS J 278: 1358–1366 (2011)
Tamai Y, et al. J Immunol 190: 4382-4392 (2013)
Tezuka K, et al. Blood 123: 346-355 (2014)
Ezinne CC, et al. PLoS One 9: e87631 (2014)
Matsuura E, et al. J Neuropathol Exp Neurol 74: 2-14 (2015)
|
| TS-M025 |
HLA-A*24:02 survivin-2B Tetramer-PE |
Kitamura H, et al. Urology 67: 955-959 (2006)
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Miyazaki A, et al. Cancer Sci. 102: 324-329 (2011)
Kameshima H, et al. Cancer Sci. 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci. 104: 124-129 (2013)
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Tanaka T, et al. Clin Dev Immunol. 2013;2013:262967. doi: 10.1155/2013/262967
|
| TB-M027-2; TB-M027-1; TB-M027-4 |
HLA-A*02:01 HIV gag Tetramer-SLYNTVATL |
Kitamura H, et al. Urology 67: 955-959 (2006)
Tsuruma T, et al. J Transl Med 6: 24 (2008)
Miyazaki A, et al. Cancer Sci. 102: 324-329 (2011)
Kameshima H, et al. Cancer Sci. 102: 1181-1187 (2011)
Kameshima H, et al. Cancer Sci. 104: 124-129 (2013)
Satomi F, et al. Int J Cancer Clin Res 2: 1-6 (2015, MBL)
Tanaka T, et al. Cancer Sci. 106: 18-24 (2015)
Tanaka T, et al. Clin Dev Immunol. 2013;2013:262967. doi: 10.1155/2013/262967
|
| TS-M036 |
HLA-B*08:01 EBV BZLF1 190-197 Tetramer-RAKFKQLL |
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI) |
| TS-M076 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV |
Mantovani S, et al. J Immunol 169: 6253-6260 (2002 BCI)
Paczesny S, et al. J Exp Med 199: 1503-1511 (2004 BCI)
|
| TS-M123 |
HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL |
Cellerai C, et al. J Virol 84: 3868–3878 (2010 BCI) |
| TS-M541; TS-M542; TS-M543 |
H-2Kb OVA Tetramer |
Teramoto K, et al. Cancer Res. 63: 7920-7925 (2003)
Li W, et al. Infect. Immun. 72: 7005-7011 (2004)
Yajima T, et al. J. Immunol. 174: 3590-3597 (2005)
Taneichi M, et al. J. Immunol. 177: 2324-2330 (2006)
Wakita D, et al. Int. Immunol. 18: 425-434 (2006)
Chamoto K, et al. Cancer Res. 66: 1809-1817 (2006)
Saito K, et al. J. Immunol. 176: 2496-2504 (2006)
Yokouchi H, et al. Cancer Sci. 97: 148-154 (2006)
Yajima T, et al. J. Immunol. 176: 507-515 (2006)
Nabekura T, et al. Molecular Therapy 13: 301–309 (2006)
Li W, et al. J Immunol 178: 4482-4488 (2007)
Zhang Y, et al. Int Immunol 19: 151-161 (2007)
Kumar H, et al. J Immunol 180: 683-687 (2008)
Wakabayashi A, et al. J Immunol 180: 4000-4010 (2008)
Miyakoda M, et al. J Immunol 181: 1420-1428 (2008)
|
| TS-M541; TS-M542; TS-M543 |
H-2Kb OVA Tetramer |
Sugiyama T, et al. Int Immunol 20: 1-9 (2008)
Tang C, et al. J Leukoc Biol 86: 187-194 (2009)
Kijima M, et al. J Immunol 182: 3566-3572 (2009)
Senju S, et al. Stem Cells 27: 1021-31 (2009)
Takeshima T, et al. Cancer Res 70: 2697-2706 (2010)
Asano J, et al. J Immunol 184: 736-745 (2010)
Kuwada E, et al. Anticancer Res 31: 881-891 (2011)
Kurachi S, et al. J Exp Med 208: 1605-1620 (2011)
Yanai H, et al. PNAS 108: 11542-11547 (2011)
Fukaya T, et al. PNAS 109: 11288-11293 (2012, MBL)
Tsukamoto H, et al. Cancer Immunology 1: 64-76 (2013)
Kimura K, et al. Infect Immun 81: 3825-3834 (2013)
Yamazaki C, et al. J Immunol 190: 6071-6082 (2013)
Shimizu K, et al. J Immunol 190: 5609-5619 (2013)
Kobiyama K, et al. PNAS 111: 3086-3091 (2014)
Ito M, et al. PLoS ONE 9: e110425 (2014, MBL)
Sasaki K, et al. Nat. Commun. 6: 7484 (2015, MBL)
Hanson MC, et al. Clin Invest 125: 2532-2546 (2015, MBLI)
Rapaport AS, et al. Immunity 43:1112-1124 (2015, MBL)
Toyota H, et al. Oncol Rep 33: 292-296 (2015, MBL)
Takada K, et al. Nat Immunol 16: 1069–1076 (2015, MBL)
Ito D, et al. J Immunol 195: 934-943 (2015, MBL)
Seregin SS, et al. J Immunol 195: 1112-1120 (2015, MBLI)
Pearce VQ, et al. J Immunol 195: 3206-3217 (2015, MBLI)
Eikawa S, et al. PNAS 112: 1809-1814 (2015, MBL)
Fu C, et al. PNAS 112: 2823-2828 (2015, MBLI)
Kamimura D, et al. Int Immunol 28: 117-126 (2016, MBL)
|
| T03004; T03005; T03004b |
Mamu-A*01 SIV gag-Tetramer-CTPYDINQM |
Cecchinato V, et al. J. Immunol. 180: 5439-5447 (2008)
Jennifer N. Rainho JN, et al. J Virol 89: 10625-10636 (2015, MBL)
|
| TS-M502 |
H-2Db Influenza NP Tetramer-PE |
Nakamura R, et al. J. Virol. 84: 5574-5582 (2010)
Takada K, et al. Nat Immunol 16: 1069–1076 (2015, MBL)
|
| TS-M503 |
H-2Kd Listeria LLO Tetramer-GYKDGNEYI |
Ozawa Y, et al. Am. J. Respir. Cell Mol. Biol. 41: 440-448 (2009)
Hayashi T, et al. J. Immunol. 182: 6360-6368 (2009)
|
| TS-M507 |
H-2Kb MuLV p15E Tetramer-KSPWFTTL |
Garnett CT, et al. Clin Cancer Res 14: 3536–3544 (2008, BCI)
Quetglas JI, et al. J Immunol 190: 2994-3004 (2013, BCI)
Cash H, et al. Oncotarget 6: 36400–36417 (2015)
Melero I, et al. Cancer Res 75: 497-507 (2015, BCI)
|
| TS-M508-1 |
H-2Db Influenza NP Tetramer-PE |
Seo S-U, et al. J Virol 84: 12713-12722 (2010)
Morimoto J, et al. J Immunol 187: 5671-5683 (2011)
Ishikawa H, et al. J Clin Immunol 32: 256-267 (2012)
|
| TS-M512 |
H-2Db LCMV gp33 (C9M) Tetramer-KAVYNFATM |
Mumprecht S, et al. Blood 113: 4681-4689 (2009, BCI)
Ohyagi H, et al. Immunity 39: 584-598 (2013)
|
| TS-M517 |
H-2Dd BCG MPT51 Tetramer-GGPHAVYLL-PE |
Nakagawa Y, et al. Int Immunol 25: 11-24 (2013, MBL) |
| TS-M518 |
H-2Db CEA Tetramer-EAQNTTYL-PE |
Hodge JW, et al. J Immunol 174: 5994-6004 (2005, BCI)
Kudo-Saito C, et al. Clin Cancer Res 11: 2416-2426 (2005, BCI)
Garnett CT, et al. Clin Cancer Res 14: 3536–3544 (2008, BCI)
Loisel-Meyer S, et al. Mol Cancer Ther 8: 692–702 (2009, BCI)
|
| TS-M520-1 |
H-2Kd Influenza HA Tetramer-PE |
Huang X, et al. Immunology 118: 361-371 (2006 BCI)
Kayamuro H, et al. J. Virol. 84: 12703-12712 (2010)
|
| TS-M523-1 |
H-2Kb HSV-1 gB Tetramer-SSIEFARL-PE |
Fukaya T, et al. PNAS 109: 11288-11293 (2012, MBL)
Imai T, et al. PLoS ONE 8: e72050 (2013, MBL)
Aoki R, et al. J Invest Dermatol 133: 2170–2179 (2013, MBL)
|
| TB-M524-1 |
H-2Db HY Uty Tetramer-WMHHNMDLI-PE |
Cheung K, et al PNAS 112: E5815-E5824 (2015, MBL) |
| TB-M539-1 |
H-2Db SV40 large T Ag 206-215 Tetramer-SAINNYAQKL |
Bunse M, et al. Mol Ther 22: 1983-1991 (2014, BCI) |
| TS-M546 |
H-2Db gp100 Tetramer-EGSRNQDWL-PE |
Betts MR, et al. J Immunol 172: 6407-6417 (2004, BCI)
Akiyama Y, et al. J. Transl. Med. 3: 4-13 (2005)
Jalili A, et al. Blood 106: 3538-3545 (2005)
Miyagawa N, et al. Oncology 70: 54-62 (2006)
Kozako T, et al. J. Immunol. 177: 5718-5726 (2006)
Santomasso BD, et al. PNAS 104: 19073-19078 (2007 BCI)
Akimoto M, et al. J. Med Virol. 79: 977-86 (2007)
Harao M, et al. Int J Cancer 123: 2616-2625 (2008)
Tsukahara T, et al. Cancer Sci. 99: 368-375 (2008)
Wakabayashi A, et al. J. Immunol.180: 4000-4010 (2008)
Suemori K, et al. J. Gen. Virol. 90: 1806-1811 (2009)
Tsukamoto T, et al. J. Virol. 83: 9339-9346 (2009)
Akiyama Y, et al. Anticancer Res. 29: 647-655 (2009)
Yoshizaki M, et al. Blood 114: 1518-1527 (2009)
Takatsuka N, et al. Int. Immunol. 21: 1089-1100 (2009)
Kobayashi E, et al. Nature Med 19: 1542–1546 (2013)
Suzuki H, et al. J Transl Med 11: 97 (2013)
Tomita Y, et al. OncoImmunology 3: e28100 (2014)
Imamura Y, et al. PLoS ONE 11: e0152384 (2016)
|
| TS-M707-1 |
I-Ab ESAT-6 1-20 Tetramer-PE |
Liao T-YA, et al. PLoS ONE 10: e0145833 (2015, MBL) |
| TS-MCD-1 |
Mouse CD1d Tetramer-PE |
Yoshiga Y, et al. Clin Exp Immunol. 164: 236–247 (2011)
Horikoshi M, et al. PLoS One 7: e51215 (2012)
Nakamura T, et al. J Control Release 171: 216–224 (2013)
Sekiya T, et al. Nat Immunol 14: 230–237 (2013)
Adachi K, et al. PLoS One 9: e96042 (2014)
|
| AM-1005 |
IMMUNOCYTO Cytotoxicity Detection Kit |
Kudo-Saito C, et al. Cancer Cell 15: 195-206 (2009)
Tanaka Y, et al. Cancer Res. 70: 6181-6192 (2010)
|
| 4844 |
IMMUNOCYTO CD107a Detection Kit |
Sabouri AH, et al. Blood 112: 2411-2420 (2008)
PLOS ONE 2014 DOI: 10.1371/journal.pone.0087631
|
| D271-4 |
Anti-mouse CD8 (clone KT15) |
Asano J, et al. J. Immunol. 184: 736-745 (2010)
Kayamuro H, et al. J. Virol. 84: 12703-12712 (2010)
Nobuoka D, et al. Cancer Immunol Immunother 62:639–652 (2013)
Ohyagi H, et al. Immunity 39: 584-598 (2013)
Cash H, et al. Oncotarget 6: 36400–36417 (2015)
Toyota H, et al. Oncol Rep 33: 292-296 (2015)
Kamimura D, et al. Int Immunol 28: 117-126 (2016, MBL)
|
| TS-M501P |
H-2Kb OVA peptide |
Tomala J, et al. J Immunol 183: 4904-4912 (2009, MBLI)
Holubova J, et al. Infect Immun 80: 1181-1192 (2012)
|
| TS-M521-P |
H-2Ld MuLV gp70 peptide |
Ishihara M, et al. PLOS ONE 9:e104669 (2014) |
| MTG-001 |
Clear Back |
Kobayashi M, et al. J Ovarian Res 7: 48 (2014) |
